These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32420773)

  • 1. Discovery and antibacterial study of potential PPK1 inhibitors against uropathogenic
    Peng L; Zeng L; Jin H; Yang L; Xiao Y; Lan Z; Yu Z; Ouyang S; Zhang L; Sun N
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1224-1232. PubMed ID: 32420773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda.
    Katongole P; Nalubega F; Florence NC; Asiimwe B; Andia I
    BMC Infect Dis; 2020 Jun; 20(1):453. PubMed ID: 32600258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic cranberry juice combinations with natural-borne antimicrobials for the eradication of uropathogenic Escherichia coli biofilm within a short time.
    Kim HW; Chung DH; Kim SA; Rhee MS
    Lett Appl Microbiol; 2019 Apr; 68(4):321-328. PubMed ID: 30801748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic mode of action of catechin, vanillic and protocatechuic acids to inhibit the adhesion of uropathogenic Escherichia coli on silicone surfaces.
    Bernal-Mercado AT; Gutierrez-Pacheco MM; Encinas-Basurto D; Mata-Haro V; Lopez-Zavala AA; Islas-Osuna MA; Gonzalez-Aguilar GA; Ayala-Zavala JF
    J Appl Microbiol; 2020 Feb; 128(2):387-400. PubMed ID: 31573730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different antibiotics on biofilm produced by uropathogenic Escherichia coli isolated from children with urinary tract infection.
    González MJ; Robino L; Iribarnegaray V; Zunino P; Scavone P
    Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28505288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli.
    Amalaradjou MA; Narayanan A; Baskaran SA; Venkitanarayanan K
    J Urol; 2010 Jul; 184(1):358-63. PubMed ID: 20488489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death and biomass reduction in biofilms of multidrug resistant extended spectrum β-lactamase-producing uropathogenic Escherichia coli isolates by 1,8-cineole.
    Vazquez NM; Mariani F; Torres PS; Moreno S; Galván EM
    PLoS One; 2020; 15(11):e0241978. PubMed ID: 33152054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose furoic acid ester: An effective quorum sensing inhibitor against uropathogenic Escherichia coli.
    Vinothkannan R; Muthu Tamizh M; David Raj C; Adline Princy S
    Bioorg Chem; 2018 Sep; 79():310-318. PubMed ID: 29800818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
    González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L
    Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilm and multidrug resistance in uropathogenic Escherichia coli.
    Mittal S; Sharma M; Chaudhary U
    Pathog Glob Health; 2015 Feb; 109(1):26-9. PubMed ID: 25605466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal.
    Shrestha R; Khanal S; Poudel P; Khadayat K; Ghaju S; Bhandari A; Lekhak S; Pant ND; Sharma M; Marasini BP
    Ann Clin Microbiol Antimicrob; 2019 Dec; 18(1):42. PubMed ID: 31847837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition and Inactivation of Uropathogenic
    Narayanan A; Nair MS; Muyyarikkandy MS; Amalaradjou MA
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29880781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) against the virulence of uropathogenic Escherichia coli.
    Ranfaing J; Dunyach-Remy C; Louis L; Lavigne JP; Sotto A
    Sci Rep; 2018 Jul; 8(1):10706. PubMed ID: 30013052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in recipient ability of uropathogenic Escherichia coli strains in relation with their pathogenic potential.
    Kuznetsova MV; Maslennikova IL; Pospelova JS; Žgur Bertok D; Starčič Erjavec M
    Infect Genet Evol; 2022 Jan; 97():105160. PubMed ID: 34839025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
    Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of AmpC β-lactamase and adherence factors in uropathogenic Escherichia coli isolated from aged patients.
    Singh SK; Seema K; Gupta M
    Microb Pathog; 2016 Nov; 100():293-298. PubMed ID: 27744103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Ranking of Clinical Compounds with Activity Against Log-phase Growing Uropathogenic Escherichia coli.
    Niu H; Yee R; Cui P; Zhang S; Tian L; Shi W; Sullivan D; Zhu B; Zhang W; Zhang Y
    Curr Drug Discov Technol; 2020; 17(2):191-196. PubMed ID: 30088449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba.
    Regasa Dadi B; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    J Infect Dev Ctries; 2018 Aug; 12(8):608-615. PubMed ID: 31958322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of acute urinary tract infections caused by uropathogenic
    Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
    Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.